PCMI
ABMD

Paradigm Capital Management Inc’s Abiomed Inc ABMD Stock Holding History

Paradigm Capital Management Inc’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-22,400
Closed -$853K – 235
2014
Q4 		$853K Hold
22,400
– – 0.08% 154
2014
Q3 		$556K Buy
+22,400
New +$567K 0.05% 201

Other funds holding ABMD

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Paradigm Capital Management Inc's ABMD Position: Q1 2015 in Review

Paradigm Capital Management Inc sold out of Abiomed Inc (ABMD) in Q1 2015, closing a stake of 22,400 shares — an estimated $853K sold.

Paradigm Capital Management Inc first reported a position in ABMD in Q3 2014 and held it in 2 quarters. The position peaked at $853K in Q4 2014. 210 funds tracked by Wall St. Rank hold ABMD as of Q1 2015.

  • Paradigm Capital Management Inc reported no remaining Abiomed Inc position as of Q1 2015 after selling out during the quarter.
  • Paradigm Capital Management Inc sold 22,400 Abiomed Inc shares in Q1 2015, an estimated $853K.
  • Paradigm Capital Management Inc first reported a position in Abiomed Inc in Q3 2014 and held it in 2 quarters.
  • Paradigm Capital Management Inc's Abiomed Inc position peaked at $853K in Q4 2014.
  • 210 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2015.

Based on Paradigm Capital Management Inc's 13F filing for Q1 2015, filed 12 May 2015.